Gynesonics wins FDA nod for VizAblate pilot trial

Gynesonics wins investigational device exemption from the FDA for a pilot trial of its VizAblate uterine fibroid treatment.

Gynesonics said it won an FDA investigational device exemption for its VizAblate system with an outpatient option for treating symptomatic uterine fibroids.

Food & Drug Administration (FDA), Gynesonics

News Well, Clinical Trials, Investigational Device Exemption (IDE), Gynecological

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1D1HN5J